FindTrial
Sign In

The role of mitomycin C (MMC) in Endoscopic Sinus Surgery (ESS) to the frontonasal recess: a prospective randomised trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN52870636
Enrollment
Unknown
Registered
2004-11-02
Start date
2004-01-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Rhinosinusitis (CRS) of the frontonasal recess Ear, Nose and Throat Chronic rhinosinusitis

Interventions

Application of MMC/placebo following ESS and assessment for impact on symptoms of CRS

Sponsors

Royal National Throat, Nose and Ear Hospital (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients who will be undergoing normal surgical procedure following the failure of medical treatment.

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

MeasureTime frame
Not provided at time of registration—

Secondary

MeasureTime frame
Not provided at time of registration—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026